Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation

Am J Hematol. 2019 Oct;94(10):E270-E272. doi: 10.1002/ajh.25590. Epub 2019 Aug 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Allografts
  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Antibody Specificity
  • Cyclosporine / therapeutic use
  • Female
  • Graft vs Host Disease / prevention & control
  • Humans
  • Immunoglobulin G / blood*
  • Immunoglobulin G / immunology
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Measles Vaccine
  • Measles virus / immunology*
  • Middle Aged
  • Mycophenolic Acid / therapeutic use
  • Myeloablative Agonists / adverse effects
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • Tacrolimus / therapeutic use
  • Time Factors
  • Transplantation Conditioning / adverse effects

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Measles Vaccine
  • Myeloablative Agonists
  • Cyclosporine
  • Mycophenolic Acid
  • Tacrolimus